All filters
Slidesets
RNA interference- Bill Symonds, PharmD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Other virological mechanisms- Stephen Locarnini, BSc, PhD, MBBS, FRCP
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Innovative trial design- Henry Lik Yuen Chan
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Combination therapy how to navigate in a minefield of efficacy and toxicity?- Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Understanding complexities of gut microbiome dysbiosis in HIV infected populations using a large cohor- Abigail Armstrong
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
Differential responses of colonic ILCs to gut commensal bacteria altered during HIV infection- Moriah Castleman, PhD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
Milk - guiding the infant microbiome - Bruce German, PhD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
The microbial-derived short chain fatty acid butyrate directly and differentially inhibits gut T helper cell subset activation and proliferation- Jon Kibbie
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
Opening Lecture: Brain-Gut-Microbiota interactions and intestinal health- Wendy Henderson, PhD, MSN, CRNP
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
Role of the microbiome in HIV vaccine response heterogeneity- James Kublin, MD, MPH
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
Microbial colonization of the gut and brain development in infancy- Rebecca Knickmeyer, PhD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
Microbial dysbiosis does not alter immune activation or disease progression in SIV-infected rhesus macaques- Alexandra Ortiz
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
Cervicovaginal microbial dynamics and its impact on HIV acquisition risk- Douglas Kwon, MD, PhD
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
Vaginal lactic acid inhibits production of pro-inflammatory mediators from human cervicovaginal epithelial cells associated with HIV acquisition- Gilda Tachedjian
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
Modulation of gut microbiota by indoleamine 2,3-dioxygenase 1 inhibitor during antiretroviral suppressed SIV infection in rhesus macaques- Zhang Wang
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
Effect of high-risk sexual behaviouron diversity of the vaginal microbiota and abundance of lactobacillus- Jocelyn Wessels
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
Exposure-Response Analysis of Lee 1810, a Lead Spectinamide Antibiotic in Mycobacterium tuberculosis Infected Mice- Santosh Wagh
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
Improved efficacy of a cofactor-independent InhA inhibitor revealed by the C3HeB/ FeJ mouse model- Gregory Robertson
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
High dose rifampicin for the treatment of TB meningitis: a dose finding study- Rob Aarnoutse, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
Ototoxicity is associated with exposure to kanamycin and capreomycin in the treatment of multidrug-resistant tuberculosis- Mohammed Aslshaer
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
A Cardiac Risk Algorithm to Predict the Probability of Drug-Induced Torsades de Pointes with Novel Anti-TB Agents- Alexander Berg, PharmD, PhD, FCP
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017
Slidesets
Pharmacokinetics of rifampicin in African children - Evaluation of the new WHO dosing guidelines- Paolo Denti
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2017